New hope for advanced tumors: FS-8002 enters first human trial
Disease control
Recruiting now
This early-stage trial tests a new drug called FS-8002 in 66 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for side effects. Researchers will also look at how the drug moves through the body and …
Phase: PHASE1 • Sponsor: Shanghai Pushi Medical Science Co. Ltd • Aim: Disease control
Last updated May 15, 2026 11:54 UTC